Abstract:Objective To study programmed death-1 (PD-1) and T-cell immunoglobulin mucin3 (Tim-3) co-expression on peripheral blood mononuclear cells (PBMC) and hepatitis B virus (HBV)-specific CD8+ T cells in patients with chronic HBV infection and its correlation with liver inflammatory activities.Methods One hundred and sixty subjects with chronic HBV infection who visited the outpatient and inpatient Department of Infectious Diseases in the Third Affiliated Hospital of Sun Yatsen University were enrolled,including 63 cases of mild or moderate CHB (MCHB),31 of severe CHB (SCHB),55 of acute-on-chronic liver failure (ACLF) and 11 inactive HBsAg carriers.Twenty healthy subjects were enrolled as controls.Real-time quantitative polymerase chain reaction (qRT-PCR) was used to detect HBV DNA,enzyme-linked immunosorbent assay (ELISA) to measure HBV serological markers,and flow cytometry to detect human leukocyte antigen (HLA)-A2 and determine the expression of PD-1 and Tim-3 on PBMC and HBV-specific CD8+ T cells.Cell counts of Tim-3+,PD-1+,and Tim-3+/PD1+ PBMC and HBV-specific CD8+ T cells were compared among different groups,and their correlation with commonly used inflammatory activity indicators were studied.Analysis of variance and Kruskal-Wallis test were used for measurement data with gaussian distribution and skewed distribution,respectively.Spearman correlation analysis was used to assess the association between Tim-3/PD-1 expression and inflammatory activity indicators.Results The frequency of Tim-3+/PD-1+ PBMC was 0.25 ％ in ACLF group (P=0.0049),0.24 ％ in SCHB group (P-0.0025) and 0.13％ in MCHB group (P=0.0006),which were significantly higher than that in control group (0.03％),and the frequency of Tim-3 /PD-1-PBMC in the three groups were significantly lower than that in control group (P =0.0000),but the differences between HBsAg carriers (0.10％) and controls (0.03％) were not statistically significant (P=0.28).Among 160 subjects,78 were HLA-A2 positive.The frequency of Tim-3+/PD-1+ HBV-specific CD8+ T cells was 68.72％±17.21％ in ACLF group,and 59.66％± 19.25％ in SCHB group,which were significantly higher than that in HBsAg carrier group (33.93％ ± 10.80％,P=0.0000,P=0.0054).The frequency of Tim-3 /PD-1-HBV-specific CD8+ T cells in ACLF group was 2.80％,which was significantly lower than that in HBsAg carrier group (27.24％,P=0.0004).The frequency of Tim3+/PD-1+ HBV-specific CD8+ T cells was positively correlated with alanine aminotransferase (r=0.26,P=0.022),aspartate aminotransferase (r=0.28,P=0.012) and total bilirubin levels (r=0.36,P=0.001); and inversely correlated with albumin level (r=-0.35,P=0.002) in serum.Furthermore,it was positively correlated with international normalized ratio (INR,r=0.34,P =0.045) and model for end-stage liver disease score (r=0.43,P=0.027) in ACLF group.Conclusions Co-expressions of Tim-3 and PD-1 on PBMC and HBV-specific CD8+ T cells are significantly upregulated in patients with CHB,and correlated with liver inflammatory activities.These findings indicate that Tim-3 and PD-1 co-expression may involve in disease activity and liver failure in CHB.

Correlation Between Clinical Stages of HBV Chronic Infection and Co-Expression of CD244 and PD-1 in HBV-specific CTLs

Changes of Costimulatory Molecule CD28 on Circulating CD8+ T Cells Correlate with Disease Pathogenesis of Chronic Hepatitis B.

Correlation of programmed death-1 and programmed death-1 ligand expressions with hepatitis B virus DNA in chronic hepatitis B virus infection patients

The expressions of PD-1 and PD-L1 and the correlation with the degree of liver damage in HBV chronic infection

Correlation between programmed death-1 and T-cell immunoglobulin mucin-3 co-expression on hepatitis B virus-specific CD8+ T cells and liver inflammatory activities in patients with chronic hepatitis B virus infection

[Detection of HBV Specific Cytotoxic Lymphocytes Responses in Severe Hepatitis B Patients Using MHC-peptide Tetramer Flow Cytometry].

CD28 Family of Receptors on T Cells in Chronic HBV Infection: Expression Characteristics, Clinical Significance and Correlations with PD-1 Blockade.

Expression of PD-1 on T Cells in Patients with Chronic Hepatitis B at Early Phase of Antiviral Treatment

Clinical Significance of Dynamics of Programmed Death Ligand-1 Expression on Circulating CD14 Monocytes and CD19 B Cells with the Progression of Hepatitis B Virus Infection.

Expression of Costimulate Molecules on Peripheral Cytotoxic T Cell in Patients with Acute-on-chronic Liver Failure and Clinic Significance

The Expression And Clinical Significance Of Pd-1 In Chronic Hepatitis B

Circulating Cd4(+)Cd25(High) Regulatory T Cells And Expression Of Pd-1 And Btla On Cd4(+) T Cells In Patients With Chronic Hepatitis B Virus Infection

Expressions of natural killer-associated receptors on cytotoxic T lymphocyte from peripheral blood of patients with chronic hepatitis B

Relationship Between Expression of Toll-Like Receptors 2/4 in Dendritic Cells and Chronic Hepatitis B Virus Infection.

Discrepant Clinical Significance of CD28(+)CD8(-) and CD4(+)CD25(high) Regulatory T Cells During the Progression of Hepatitis B Virus Infection

Programmed death-1 expression is associated with the disease status in hepatitis B virus infection.

Intrahepatic levels of PD-1/PD-L correlate with liver inflammation in chronic hepatitis B

The role of CD4+C D25+ regulatory T cells in the pathogenesis of severe hepatitis B

Programmed Death 1 and Programmed Death Ligand 1 Expressions in Patients with Chronic Hepatitis B

Cytokine profiles and CD8+ T cells in the occurrence of acute and chronic hepatitis B

The research of CD4+CD25+Treg and partial cytokines from patients with chronic hepatitis B